Cancer Discovery
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based TherapiesAbstract Glioblastoma (GBM) contains self-renewing GBM stem cells (GSC) potentially amenable to immunologic targeting, but chimeric antigen receptor (CAR) T-cell therapy has demonstrated limited clinical responses in GBM. Here, we interrogated molecular determinants of CAR-mediated GBM killing through whole-genome CRISPR screens in both CAR T... ... hiện toàn bộ
Cancer Discovery - Tập 11 Số 5 - Trang 1192-1211 - 2021
MYC, Metabolism, and CancerAbstract
The MYC oncogene encodes a transcription factor, MYC, whose broad effects make its precise oncogenic role enigmatically elusive. The evidence to date suggests that MYC triggers selective gene expression amplification to promote cell growth and proliferation. Through its targets, MYC coordinates nutrient acquisition to produce ATP and key cel... ... hiện toàn bộ
Cancer Discovery - Tập 5 Số 10 - Trang 1024-1039 - 2015
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Cancer Discovery - Tập 7 Số 9 - Trang 984-998 - 2017
The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung CancerAbstract
Non–small cell lung cancers (NSCLC) harboring anaplastic lymphoma kinase (ALK) gene rearrangements invariably develop resistance to the ALK tyrosine kinase inhibitor (TKI) crizotinib. Herein, we report the first preclinical evaluation of the next-generation ALK TKI, ceritinib (LDK378), in the setting of crizotinib resistance. An interrogatio... ... hiện toàn bộ
Cancer Discovery - Tập 4 Số 6 - Trang 662-673 - 2014
Targeting Autophagy in Cancer: Recent Advances and Future DirectionsAbstract Autophagy, a multistep lysosomal degradation pathway that supports nutrient recycling and metabolic adaptation, has been implicated as a process that regulates cancer. Although autophagy induction may limit the development of tumors, evidence in mouse models demonstrates that autophagy inhibition can limit the growth of established tu... ... hiện toàn bộ
Cancer Discovery - Tập 9 Số 9 - Trang 1167-1181 - 2019
Mutant N-RAS Protects Colorectal Cancer Cells from Stress-Induced Apoptosis and Contributes to Cancer Development and ProgressionAbstract
N-RAS is one member of a family of oncoproteins that are commonly mutated in cancer. Activating mutations in NRAS occur in a subset of colorectal cancers, but little is known about how the mutant protein contributes to the onset and progression of the disease. Using genetically engineered mice, we find that mutant N-RAS strongly promotes tum... ... hiện toàn bộ
Cancer Discovery - Tập 3 Số 3 - Trang 294-307 - 2013
Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in Nras-Driven Hematopoietic TransformationAbstract
Biochemical properties of Ras oncoproteins and their transforming ability strongly support a dominant mechanism of action in tumorigenesis. However, genetic studies unexpectedly suggested that wild-type (WT) Ras exerts tumor suppressor activity. Expressing oncogenic NrasG12D in the hematopoietic compartment of mice induces an aggressive myel... ... hiện toàn bộ
Cancer Discovery - Tập 3 Số 9 - Trang 993-1001 - 2013
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic VulnerabilitiesAbstract
The molecular underpinnings that drive the heterogeneity of KRAS-mutant lung adenocarcinoma are poorly characterized. We performed an integrative analysis of genomic, transcriptomic, and proteomic data from early-stage and chemorefractory lung adenocarcinoma and identified three robust subsets of KRAS-mutant lung adenocarcinoma dominated, re... ... hiện toàn bộ
Cancer Discovery - Tập 5 Số 8 - Trang 860-877 - 2015
Genetic Predictors of Response to Systemic Therapy in Esophagogastric CancerAbstract
The incidence of esophagogastric cancer is rapidly rising, but only a minority of patients derive durable benefit from current therapies. Chemotherapy as well as anti-HER2 and PD-1 antibodies are standard treatments. To identify predictive biomarkers of drug sensitivity and mechanisms of resistance, we implemented prospective tumor sequencin... ... hiện toàn bộ
Cancer Discovery - Tập 8 Số 1 - Trang 49-58 - 2018
Cổng thông tin cBio Genomics về ung thư: Nền tảng mở cho khám phá dữ liệu genomics ung thư đa chiều Dịch bởi AI Tóm tắt
Cổng thông tin cBio Genomics về ung thư (http://cbioportal.org... ... hiện toàn bộ
Cancer Discovery - Tập 2 Số 5 - Trang 401-404 - 2012
#Genomics ung thư #cổng thông tin cBio #dữ liệu đa chiều #nghiên cứu ung thư #bộ dữ liệu genomics #phân tử và thuộc tính lâm sàng
Tổng số: 92
- 1
- 2
- 3
- 4
- 5
- 6
- 10